160 related articles for article (PubMed ID: 38128748)
1. Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study.
Solitano V; Facheris P; Petersen M; D'Amico F; Ortoncelli M; Aletaha D; Olivera PA; Bieber T; Ramiro S; Ghosh S; D'Agostino MA; Siegmund B; Chary-Valckenaere I; Hart A; Dagna L; Magro F; Felten R; Kotze PG; Jairath V; Costanzo A; Kristensen LE; Biroulet LP; Danese S
Autoimmun Rev; 2024 Mar; 23(3):103504. PubMed ID: 38128748
[TBL] [Abstract][Full Text] [Related]
2. A detailed look at the European Medicines Agency's recommendations for use of Janus kinase inhibitors in patients with atopic dermatitis.
Wollenberg A; Thyssen JP; Bieber T; Chan G; Kerkmann U
J Eur Acad Dermatol Venereol; 2023 Oct; 37(10):2041-2046. PubMed ID: 37319107
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the appropriateness of cardiovascular preventive medication in older people: using the RAND/UCLA Appropriateness Method.
van der Ploeg MA; Poortvliet RKE; Achterberg WP; Mooijaart SP; Gussekloo J; Drewes YM
BMC Geriatr; 2022 May; 22(1):394. PubMed ID: 35513798
[TBL] [Abstract][Full Text] [Related]
4. Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process.
Barber CE; Marshall DA; Alvarez N; Mancini GB; Lacaille D; Keeling S; Aviña-Zubieta JA; Khodyakov D; Barnabe C; Faris P; Smith A; Noormohamed R; Hazlewood G; Martin LO; Esdaile JM;
J Rheumatol; 2015 Sep; 42(9):1548-55. PubMed ID: 26178275
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for assessing the risk of cardiovascular disease and venous thromboembolism before the initiation of targeted therapies for chronic inflammatory rheumatic diseases.
Avouac J; Fogel O; Hecquet S; Daien C; Elalamy I; Picard F; Prati C; Salmon JH; Truchetet ME; Sellam J; Molto A;
Joint Bone Spine; 2023 Sep; 90(5):105592. PubMed ID: 37201575
[TBL] [Abstract][Full Text] [Related]
7. An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials.
Ma C; Sedano R; Almradi A; Vande Casteele N; Parker CE; Guizzetti L; Schaeffer DF; Riddell RH; Pai RK; Battat R; Sands BE; Rosty C; Dubinsky MC; Rieder F; Harpaz N; Abreu MT; Bryant RV; Lauwers GY; Kirsch R; Valasek MA; Crowley E; Sandborn WJ; Feagan BG; Pai RK; Jairath V
Gastroenterology; 2021 Jun; 160(7):2291-2302. PubMed ID: 33610533
[TBL] [Abstract][Full Text] [Related]
8. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research.
Kerschbaumer A; Smolen JS; Nash P; Doerner T; Dougados M; Fleischmann R; Geissler K; McInnes IB; Takeuchi T; Trauner M; Winthrop K; de Wit M; Boehncke WH; Falzon L; van der Heijde D
RMD Open; 2020 Nov; 6(3):. PubMed ID: 33188136
[TBL] [Abstract][Full Text] [Related]
9. Appropriateness of methadone maintenance treatment for opiate addiction: evaluation by an expert panel.
Vader JP; Hämmig R; Besson J; Eastus C; Eggenberger C; Burnand B
Soz Praventivmed; 2003; 48 Suppl 1():S1-14. PubMed ID: 12891872
[TBL] [Abstract][Full Text] [Related]
10. Development of a Metric to Detect and Decrease Low-Value Prescribing in Older Adults.
Radomski TR; Decker A; Khodyakov D; Thorpe CT; Hanlon JT; Roberts MS; Fine MJ; Gellad WF
JAMA Netw Open; 2022 Feb; 5(2):e2148599. PubMed ID: 35166780
[TBL] [Abstract][Full Text] [Related]
11. Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors.
Yang V; Kragstrup TW; McMaster C; Reid P; Singh N; Haysen SR; Robinson PC; Liew DFL
Drug Saf; 2023 Nov; 46(11):1049-1071. PubMed ID: 37490213
[TBL] [Abstract][Full Text] [Related]
12. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
13. International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients.
Caron B; Jairath V; D'Amico F; Al Awadhi S; Dignass A; Hart AL; Kobayashi T; Kotze PG; Magro F; Siegmund B; Paridaens K; Danese S; Peyrin-Biroulet L
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676807
[No Abstract] [Full Text] [Related]
14. JAK inhibitors for the treatment of inflammatory bowel disease: results of an international survey of perceptions, attitudes, and clinical practice.
Honap S; Irving PM; Samaan MA
Eur J Gastroenterol Hepatol; 2023 Nov; 35(11):1270-1277. PubMed ID: 37724470
[TBL] [Abstract][Full Text] [Related]
15. Delphi-based recommendations for the management of cardiovascular comorbidities in patients with psoriatic arthritis and moderate-to-severe psoriasis.
Zarco Montejo P; Almodóvar González R; De Higes-Martínez E; Gorgojo-Martínez JJ; Guijarro Herraiz C; López Navas MJ; Palacios D; Peláez Álvarez JC; Ruíz Genao D; Piedrafita B; Gómez S; Falkenbach E; Rebollo Laserna FJ; López Estebaranz JL
Rheumatol Int; 2020 Jun; 40(6):969-981. PubMed ID: 32274527
[TBL] [Abstract][Full Text] [Related]
16. Major adverse cardiovascular events in patients with atopic dermatitis treated with oral Janus kinase inhibitors: a systematic review and meta-analysis.
Ertus C; Scailteux LM; Lescoat A; Berthe P; Auffret V; Dupuy A; Oger E; Droitcourt C
Br J Dermatol; 2023 Sep; 189(4):368-380. PubMed ID: 37410552
[TBL] [Abstract][Full Text] [Related]
17. Risk of cancer, cardiovascular disease, thromboembolism, and mortality in patients with rheumatoid arthritis receiving Janus kinase inhibitors: a real-world retrospective observational study using Korean health insurance data.
Min HK; Kim H; Jeong HJ; Kim SH; Kim HR; Lee SH; Lee K; Shin SA; Park JH
Epidemiol Health; 2023; 45():e2023045. PubMed ID: 37080728
[TBL] [Abstract][Full Text] [Related]
18. Development and appropriateness of a scoring method for International Classification of Functioning, Disabilities, and Health assessment in older patients with heart failure: a Delphi survey of expert panel in Japan.
Shiota S; Kitagawa T; Goto N; Fujisita H; Tamekuni Y; Nakayama S; Mio N; Kanai K; Naka M; Yamaguchi M; Mochizuki M; Ochikubo H; Hidaka T; Yasunobu Y; Nakano Y; Kihara Y; Kimura H
BMJ Open; 2022 Sep; 12(9):e060609. PubMed ID: 36115681
[TBL] [Abstract][Full Text] [Related]
19. JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications.
Russell MD; Stovin C; Alveyn E; Adeyemi O; Chan CKD; Patel V; Adas MA; Atzeni F; Ng KKH; Rutherford AI; Norton S; Cope AP; Galloway JB
Ann Rheum Dis; 2023 Aug; 82(8):1059-1067. PubMed ID: 37247942
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
